Growth Metrics

Baxter International (BAX) Invested Capital (2016 - 2025)

Baxter International (BAX) has disclosed Invested Capital for 17 consecutive years, with $6.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 69.7% to $6.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 billion, a 69.7% decrease, with the full-year FY2025 number at $6.1 billion, down 69.7% from a year prior.
  • Invested Capital was $6.1 billion for Q4 2025 at Baxter International, down from $7.2 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $26.9 billion in Q4 2021 to a low of $5.9 billion in Q3 2022.
  • A 5-year average of $11.5 billion and a median of $9.7 billion in 2022 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 80.91% in 2024, then crashed 69.7% in 2025.
  • Baxter International's Invested Capital stood at $26.9 billion in 2021, then decreased by 20.28% to $21.4 billion in 2022, then tumbled by 48.03% to $11.1 billion in 2023, then skyrocketed by 80.91% to $20.1 billion in 2024, then plummeted by 69.7% to $6.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BAX's Invested Capital are $6.1 billion (Q4 2025), $7.2 billion (Q3 2025), and $7.3 billion (Q2 2025).